ArticleAnnals of surgical oncology2026

Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

Yuko Ueki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.